AllianceBernstein’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-77,300
| Closed | -$1.37M | – | 3176 |
|
|
2018
Q3 | $1.37M | Hold |
77,300
| – | – | ﹤0.01% | 2172 |
|
|
2018
Q2 | $1.07M | Sell |
77,300
-122,700
| -61% | -$1.46M | ﹤0.01% | 2284 |
|
|
2018
Q1 | $1.82M | Buy |
+200,000
| New | +$1.1M | ﹤0.01% | 1891 |
|
|
2017
Q2 | – | Sell |
-19,500
| Closed | -$50K | – | 3207 |
|
|
2017
Q1 | $50K | Hold |
19,500
| – | – | ﹤0.01% | 2968 |
|
|
2016
Q4 | $50K | Hold |
19,500
| – | – | ﹤0.01% | 2994 |
|
|
2016
Q3 | $60K | Sell |
19,500
-1,500
| -7% | -$4.67K | ﹤0.01% | 2950 |
|
|
2016
Q2 | $67K | Buy |
21,000
+2,800
| +15% | +$10.3K | ﹤0.01% | 2940 |
|
|
2016
Q1 | $56K | Sell |
18,200
-5,900
| -24% | -$19.3K | ﹤0.01% | 2872 |
|
|
2015
Q4 | $97K | Hold |
24,100
| – | – | ﹤0.01% | 2850 |
|
|
2015
Q3 | $110K | Hold |
24,100
| – | – | ﹤0.01% | 2869 |
|
|
2015
Q2 | $125K | Buy |
24,100
+3,500
| +17% | +$21K | ﹤0.01% | 2935 |
|
|
2015
Q1 | $129K | Sell |
20,600
-5,800
| -22% | -$33.5K | ﹤0.01% | 2966 |
|
|
2014
Q4 | $166K | Sell |
26,400
-8,100
| -23% | -$49.4K | ﹤0.01% | 2861 |
|
|
2014
Q3 | $210K | Hold |
34,500
| – | – | ﹤0.01% | 2753 |
|
|
2014
Q2 | $227K | Sell |
34,500
-22,327
| -39% | -$251K | ﹤0.01% | 2778 |
|
|
2014
Q1 | $1.35M | Sell |
56,827
-4,494
| -7% | -$65.2K | ﹤0.01% | 1985 |
|
|
2013
Q4 | $656K | Sell |
61,321
-7,700
| -11% | -$85K | ﹤0.01% | 2335 |
|
|
2013
Q3 | $920K | Buy |
69,021
+21
| +0% | +$332 | ﹤0.01% | 2169 |
|
|
2013
Q2 | $906K | Buy |
+69,000
| New | +$930K | ﹤0.01% | 2137 |
|
Other funds holding ECYT
AllianceBernstein's ECYT Position: Q4 2018 in Review
AllianceBernstein sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 77,300 shares — an estimated $1.37M sold.
AllianceBernstein first reported a position in ECYT in Q2 2013 and held it in 19 quarters. The position peaked at $1.82M in Q1 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.
- AllianceBernstein reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
- AllianceBernstein sold 77,300 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $1.37M.
- AllianceBernstein first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 19 quarters.
- AllianceBernstein's Endocyte, Inc. Common Stock position peaked at $1.82M in Q1 2018.
- 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.
Based on AllianceBernstein's 13F filing for Q4 2018, filed 13 Feb 2019.